Northwest closes direct financing

|About: Northwest Biotherapeut... (NWBO)|By:, SA News Editor

An institutional investor buys $15M of Northwest Biotherapeutics (NWBO) common stock for $6.60/share, an 8% discount from yesterday's close of $7.17.

The Stock Purchase Agreement also contains an oversubscription option to purchase an additional $17M at $7.50/share.

The company has been under scrutiny from certain observers regarding clinical trial data for DCVax.